Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Clascoterone cream effectively reduces acne severity and is safe for patients 12 and older.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

Lulican™ shampoo is more effective and better tolerated than Ketoconazole for treating scalp seborrheic dermatitis.

The best method to monitor dutasteride in rat plasma is liquid-liquid extraction with methyl tert-butyl ether and methylene chloride.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Low-dose oral minoxidil may help with hair loss, but more research is needed.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Spironolactone can safely lower blood pressure in patients on other blood pressure medications, but may slightly increase the risk of low blood pressure.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Sertraline can cause hair loss, which stops after stopping the drug.